Question 1

Can voice biomarkers detect Alzheimer's disease early?

Accepted Answer

Yes. digitalhumanOS™ analyzes over 2,500 speech biomarkers that change in the earliest stages of Alzheimer's disease — often before symptoms are noticeable to patients or clinicians.

Question 2

How accurate is voice-based Parkinson's screening?

Accepted Answer

Voice-based Parkinson's screening achieves an AUC of 0.97 in peer-reviewed studies, making it one of the most accurate non-invasive screening methods available.

Question 3

What neurodegenerative conditions does digitalhumanOS screen for?

Accepted Answer

digitalhumanOS™ screens for Alzheimer's disease, Parkinson's disease, mild cognitive impairment (MCI), Huntington's disease, cognitive decline, traumatic brain injury, multiple sclerosis, and hearing-related disorders.

Alzheimer’s. Parkinson’s. Huntington’s. MCI. Detected Before Symptoms Appear.

Cognitive Decline

Alzheimer's Disease

Parkinson's Disease

Mild Cognitive Impairment

Huntington's Disease

Traumatic Brain Injury

Cognitive Impairment/Deficit

Multiple Sclerosis

Hearing-related Disorders

See What You're Missing.